Various non-invasive investigations were carried out in patients infected with HIV who had respiratory symptoms with and without pneumocystis pneumonia (with pneumonia, n = 13 (five smokers); without pneumonia, n = 22 (13 smokers)). These included chest radiography; lung function tests (forced expiratory volume in one second, forced vital capacity; transfer factor and coefficient for carbon monoxide); arterial blood gas tensions; arterial oxygen saturation at rest and on exercise; and lung clearance of diethylenetriaminepenta-acetic acid labelled with technetium-99m (ssmTc DTPA). The effect of scan time (seven v 45 minutes from peak counts) and subtraction of background counts were examined. There were no significant differences between the two groups in lung function tests or arterial blood gas tensions at rest. The median clearance half time of inhaled "mTc DTPA for the first seven minutes from peak counts was 7-2 minutes for patients with pneumocystis pneumonia and 22 minutes for those without. The chest radiograph and hypoxaemia5-may no longer be tenable as pneumocystis pneumonia becomes less common relative to other infections, and as its presentation is modulated by previous prophylaxis. Diagnosis currently relies on identification of Pneumocystis carinii in respiratory secretions.2 Sputum induction has proved difficult to establish in some centres so there is a need for an effective screening test to identify patients with symptoms who will probably develop pneumocystis infection before undergoing fibreoptic bronchoscopy.
Pneumocystis pneumonia is the commonest opportunist infection in patients with AIDS, occurring in over 60% of patients.' As the pandemic of infection with HIV continues more patients will present with respiratory symptoms.
The range of pulmonary disease in such patients includes increased susceptibility to bacterial infection as well as opportunist infections and malignancy.2 Effective prophylaxis against pneumocystis pneumonia with nebulised pentamidine isethionate3 or oral drugs such as co-trimoxazole4 may alter this pattern, and empirical treatment of pneumocystis pneumonia in patients presenting with typical symptoms-changes in a chest radiograph and hypoxaemia5-may no longer be tenable as pneumocystis pneumonia becomes less common relative to other infections, and as its presentation is modulated by previous prophylaxis. Diagnosis currently relies on identification of Pneumocystis carinii in respiratory secretions.2 Sputum induction has proved difficult to establish in some centres so there is a need for an effective screening test to identify patients with symptoms who will probably develop pneumocystis infection before undergoing fibreoptic bronchoscopy.
We assessed the results of pulmonary function tests, arterial blood gas tensions, chest radiology, arterial-oxygen saturation before and after exercise, and the clearance of diethylenetriaminepenta-acetic acid labelled with technetium-99m (99mTc DTPA) in patients positive for HIV with respiratory symptoms.
Patients and methods
Patients positive for HIV presenting with respiratory symptoms were admitted to the study after giving informed consent. A full examination was performed and a full history obtained, particularly about HIV related disease, respiratory disease, and smoking.
The forced expiratory volume in one second (FEV,) Data were analysed separately for each lung with background counts from a region between the two kidneys subtracted and included.7 Curves were plotted on a semilog scale and judged visually to be either monoexponential or biexponential. A straight line was fitted to the curve by the computer with a least squares fit between two points being determined by the operator. When the curve was biexponential the slow component was subtracted from the original curve and a second straight line fitted to the new stripped data. Data for the first seven minutes after peak activity were also analysed. These curves were monoexponential and a single straight line was fitted.
Each lung was divided into upper and lower zones; curves generated for each zone were assessed visually to determine whether they were biexponential or monoexponential. Thirteen patients (five smokers) had pneumocystis pneumonia confirmed by fibreoptic bronchoscopy. Twenty two patients (13 smokers) did not have pneumocystis pneumonia; 12 had fibreoptic bronchoscopy at which P carinii was not isolated (three had endobronchial Kaposi's sarcoma, one had tuberculosis, six had bacterial pneumonia), and 10 had symptoms that resolved rapidly on treatment with either erythromycin or amoxycillin. None of these patients was treated with drugs effective against pneumocystis pneumonia.
There was no significant difference between the two groups in respiratory rate (median 20 for both groups); FEVy (85% and 93% of predicted values for those with and without pneumonia respectively); FVC (82% and 92%); TLCO (61% and 57%); Kco (71% and 78%); arterial oxygen tension (10X4 and 10-5 kPa); or arterial carbon dioxide tension (4-8 and 5 0 kPa).
Chest radiographs from eight patients with pneumocystis pneumonia had changes suggestive of opportunist infection and two were normal (in three cases chest radiographs were not available). Eighteen of the radiographs Table 2 Median values and 95% confidence intervals for difference for variables significantly different between patients positive for HIV with and without pneumocystis pneumonia figure 1 ).
Clearance half times of 9'Tc DTPA calculated from the first seven minutes after peak counts gave equal discrimination between the two groups as did the 45 minute clearance half time. Figure 2 shows examples of clearance curves of 9'9Tc DTPA from patients with and without pneumocystis pneumonia. Receiver operator curves showed the optimal cut off value for the clearance half time in the seven minutes after peak counts to be 10 minutes: this gave a sensitivity of 92% and specificity of 82% in diagnosing pneumocystis pneumonia (figure 3). 
Discussion
In our study of non-invasive tests in patients positive for HIV presenting with respiratory symptoms lung clearance of 99mTc DTPA was the best in distinguishing patients with pneumocystis pneumonia from those without. Many non-invasive tests have been used to try to distinguish pneumocystis pneumonia from other causes of respiratory symptoms. None has proved entirely successful. A chest radiograph may be normal in 5-10% of cases,89 but atypical features occur in up to 5% and other conditions may mimic pneumocystis pneumonia.'
(1-Specificity) Figure 3 Receiver operator curvesfor clearance half times of 99Tc DTPA in seven and 45 minutes after peak counts (background counts subtracted and included). Maximal resolution (top left corner) gives sensitivity of 92% and specificity of 82%.
( Abnormalities in lung function occur in most patients with pneumocystis pneumonia'01' but a reduction in FVC, TLCO, and Kco also occur in patients with AIDS without respiratory symptoms." Arterial hypoxaemia occurs in up to 80% of patients with pneumocystis pneumonia" but is a non-specific finding in pulmonary infection and may not be present early in the course of the pneumonia. 5 Arterial oxygen desaturation occurs on exercise in patients with HIV infection and pneumocystis pneumonia13 and is a useful screening test for such pneumonia in HIV positive patients with respiratory symptoms and a normal chest radiograph.'4 In our patients this test was specific but not as sensitive as lung clearance of 99mTc DTPA.
A characteristic feature of pneumocystis pneumonia is widespread alveolar infiltration and attachment of the organism to type 1 pneumocytes. '5 Changes in alveolar permeability can be detected by changes in the ratio of lung to blood clearance of inhaled`smTc DTPA.'6 When alveolar damage is severe clearance is increased above normal values and is biphasic with rapid, early clearance from the most damaged alveoli. Biphasic curves have been reported in pneumocystis pneumonia'7 and in the adult respiratory distress syndrome.'6 Other insults to the lung, such as smoking,'8 may increase the rate of clearance of 99mTc DTPA from the lung but do not result in a biphasic curve. This distinction has been used to separate HIV positive patients with pneumocystis pneumonia from those without.
Our results confirmed the increased clearance in patients who are HIV positive and have pneumocystis pneumonia and showed that the shape of the clearance curve is almost invariably biphasic. We were unable to confirm the absolute distinction between patients with and without pneumocystis pneumonia reported by O'Doherty et al,'7 perhaps because of differences in the methods used. The particle size quoted for the Venticis nebuliser has a mass median diameter of 0 9 gum whereas .that of our nebulising system has a mass median diameter of 1 4 pum at a flow rate of 10 I/min." We used a flow rate of 6 1/min because a rate of 10 1/min was difficult to maintain owing to the resistance within the separator. The aerosol particle size in our study was therefore probably larger than 1 4 ,um, and undoubtedly greater than that in the study of O'Doherty et al. 17 
